S. L. Manne, N. J. Meropol, D. S. Weinberg, H. Vig, Z. A.-K. Catts, C. Manning, E. Ross, K. Shannon and D. C. Chung, “Facilitating Informed Decisions Regarding Microsatellite Instability Testing among High-Risk Individuals Diagnosed with Colorectal Cancer,” Journal of Clinical Oncology, Vol. 28, No. 8, 2010, pp. 1366-1372. doi:10.1200/JCO.2009.25.0399
 M. Aronson, “Genetic Counselling for Hereditary Colorectal Cancer: Ethical, Legal and Psychosocial Issues,” Surgical Oncology Clinics of North America, Vol. 18, No. 4, 2009, pp. 669-685. doi:10.1016/j.soc.2009.07.001
 A. Romiti, A. Zullo, S. Tomao, C. Hassan, I Sarcina, V. D. Francesco, E. Ierardi, F. Tomao, A. Vecchione and S. Morini, “Gastric Mucosa Alterations in First-Degree Relatives of Gastric Cancer Patients,” Anticancer Reseach, Vol.25, No. 3c, 2005, pp. 2567-2572.
 D. G. Huntsman, F. Carneiro and F. R. Lewis, et al., “Early Gastric Cancer in Young, Asymptomatic Carriers of Germ-Line E-Cadherin Mutations,” The New England Journal of Medicine, Vol. 344, No. 25, 2001, pp. 1904-1909.
 G. Suriano, S. Yew and P. Ferreira, et al., “Characterization of a Recurrent Germ Line Mutation of the E-Cadherin gene: Implications for Genetic Testing and Clinical Management,” Clinical Cancer Research, Vol. 11, No. 15, 2005, pp. 5401-5409. doi:10.1158/1078-0432.CCR-05-0247